71 results
REBEL Review #91: Management of Peripheral Pressor Extravasation #peripheralpressors #vasopressors #extravasation
REBEL Review #91 ... Peripheral Pressor Extravasation ... #vasopressors #extravasation
CML Treatment Free Remission (TFR) 

 • Goals of Therapy in CML
 • CML Rx Milestones
CML Treatment Free ... of Therapy in CML ... • CML Rx Milestones ... @ZhuoerXie #CML
Algorithm for the Treatment of Uremic Pruritus
Nonpharmacologic Treatments:
 • Daily topical emollient
 • Avoidance of extremes
Algorithm for the Treatment ... Nonpharmacologic Treatments ... Pharmacologic Treatments ... max 75 mg daily Treatments ... nalfurafine 2.5 mcg
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
>10% (or >200 mL ... DLCO >15% (or 3 mL ... Symptomatic treatment ... optimization of GERD treatment ... indications #management #treatment
Hepatitis B - Treatment Indications
Treatment not indicated:
 • Immune tolerant state - HBe-Ag detectable, high HBV
Hepatitis B - Treatment ... Indications Treatment ... ), normal ALT Treatment ... history of HCC Treatment ... HepatitisB #HepBV #HBV #Treatment
Thromboelastogram Interpretation
Reaction Time (R Value):
 - Time till initiation of fibrin clot
 - Treatment: FFP, protamine
K
fibrin clot - Treatment ... interaction - Treatment ... strength of clot - Treatment ... minutes after MA/MCF ... - Treatment:
Hyperviscosity Syndrome - Causes and Treatment

 - Waldenstrom macroglobulinemia (most common) / Plasmapheresis 
 - Multiple
Syndrome - Causes and Treatment ... transformation (CML ... Differential #Diagnosis #Treatment
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Ferritin <100 ng/mL ... Ferritin 100-299 ng/mL ... algorithm #cardiology #treatment
Back to the "10 Need to Know" series - Drug Therapeutic Target Levels. 

For lithium, target
vary depending on treatment ... (0.5 - 0.8 ng/mL
Choice of anticoagulant for treatment of pulmonary embolism
 • Malignancy - LMWH
 • To avoid parenteral
anticoagulant for treatment ... clearance <30 mL